NO20051030L - Funksjonelle kardiomyocytter fra humane embryonale stamceller - Google Patents
Funksjonelle kardiomyocytter fra humane embryonale stamcellerInfo
- Publication number
- NO20051030L NO20051030L NO20051030A NO20051030A NO20051030L NO 20051030 L NO20051030 L NO 20051030L NO 20051030 A NO20051030 A NO 20051030A NO 20051030 A NO20051030 A NO 20051030A NO 20051030 L NO20051030 L NO 20051030L
- Authority
- NO
- Norway
- Prior art keywords
- embryonic stem
- stem cells
- human embryonic
- cardiomyocytes
- functional cardiomyocytes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5061—Muscle cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
2005 -04- 7 Sammendrag 0. nr. E38988 Human e embryonale stamceller danner embryoidlegemer i kultur som inneholder differensierte humane celler. Noen av de humane cellene i embryoidlegemene differensierer til kardiomyocytter. Her beskrives de biologiske og elektriske egenskaper til disse kardiomyocytter med henvisning til anvendelse av kardiomyocytter avledet fra humane embryonale stamceller ved medikamentscreeningprotokoller for mekanismer for hjertetoksisitet. (Figur 1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39933002P | 2002-07-26 | 2002-07-26 | |
PCT/US2003/023174 WO2004011603A2 (en) | 2002-07-26 | 2003-07-25 | Functional cardiomyocytes from human embryonic stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051030L true NO20051030L (no) | 2005-04-07 |
Family
ID=31188569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051030A NO20051030L (no) | 2002-07-26 | 2005-02-25 | Funksjonelle kardiomyocytter fra humane embryonale stamceller |
Country Status (14)
Country | Link |
---|---|
US (1) | US7611852B2 (no) |
EP (1) | EP1551991A4 (no) |
JP (1) | JP2005533518A (no) |
KR (1) | KR20050026008A (no) |
CN (1) | CN1671860A (no) |
AU (1) | AU2003252155B2 (no) |
BR (1) | BR0312764A (no) |
CA (1) | CA2493588C (no) |
IL (1) | IL165943A0 (no) |
IS (1) | IS7663A (no) |
MX (1) | MXPA05000283A (no) |
NO (1) | NO20051030L (no) |
NZ (1) | NZ537245A (no) |
WO (1) | WO2004011603A2 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005500847A (ja) * | 2001-08-24 | 2005-01-13 | アドバンスド セル テクノロジー、インコーポレイテッド | 分化誘導薬の同定のためのスクリーニング検定及び細胞治療用の分化細胞の調製 |
US7192752B2 (en) | 2002-12-20 | 2007-03-20 | Acea Biosciences | Real time electronic cell sensing systems and applications for cell-based assays |
US8263375B2 (en) | 2002-12-20 | 2012-09-11 | Acea Biosciences | Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology |
US10215748B2 (en) | 2002-12-20 | 2019-02-26 | Acea Biosciences, Inc. | Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways |
US9709548B2 (en) | 2008-05-05 | 2017-07-18 | Acea Biosciences, Inc. | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution |
US10539523B2 (en) | 2002-12-20 | 2020-01-21 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties |
US10551371B2 (en) | 2003-11-10 | 2020-02-04 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function |
US11346797B2 (en) | 2002-12-20 | 2022-05-31 | Agilent Technologies, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties |
AU2003901099A0 (en) * | 2003-03-11 | 2003-03-27 | Es Cell International Pte Ltd. | Methods of inducing differentiation of stem cells |
DK1740945T3 (en) | 2004-04-07 | 2019-01-21 | Ncardia Ag | KKE-INVASIVE, IN-VITRO FUNCTIONAL TISSUE TEST SYSTEMS |
CA2565858C (en) | 2004-05-11 | 2021-06-22 | Axiogenesis Ag | Assay for drug discovery based on in vitro differentiated cells |
US20050277124A1 (en) * | 2004-06-10 | 2005-12-15 | White Steven M | Cardiac conduction system cells and uses thereof |
WO2008090472A2 (en) * | 2007-01-25 | 2008-07-31 | Uti Limited Partnership | Tissue progenitor cells that overexpress erg |
WO2008112323A1 (en) * | 2007-03-15 | 2008-09-18 | California Stem Cell, Inc. | Cardiomyocytes and methods of producing and purifying cardiomyocytes |
WO2008152983A1 (ja) * | 2007-06-08 | 2008-12-18 | National University Corporation Tokyo Medical And Dental University | モデル細胞チップ、モデル細胞チップによる薬効評価装置、および薬効評価方法 |
US8603817B2 (en) | 2008-11-03 | 2013-12-10 | University Of Washington | Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling |
EP2218772A1 (en) | 2009-02-09 | 2010-08-18 | Koninklijke Philips Electronics N.V. | Cardiomyocytes-containing device and method for manufacturing the same |
WO2010094694A1 (en) * | 2009-02-23 | 2010-08-26 | F. Hoffmann-La Roche Ag | Assays to predict cardiotoxicity |
WO2011146531A1 (en) * | 2010-05-18 | 2011-11-24 | Acea Biosciences, Inc | Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments |
EP2580317B1 (en) * | 2010-06-13 | 2020-12-23 | Institute of Biophysics Chinese Academy of Sciences | Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof |
WO2012017343A2 (en) | 2010-08-05 | 2012-02-09 | Koninklijke Philips Electronics N.V. | Cardiomyocyte containing device, manufacturing method and measuring method |
KR101364965B1 (ko) * | 2010-10-06 | 2014-02-18 | (주)차바이오앤디오스텍 | 인간 배아줄기세포 유래 심근세포의 배양 및 정제 방법 |
MX2013004351A (es) * | 2010-10-29 | 2013-06-07 | Hoffmann La Roche | Metodo para determinar riesgo de arritmia. |
WO2013006364A1 (en) | 2011-07-05 | 2013-01-10 | Baylor Research Institute | Establishment of patient - or person - specific cardiac myocyte cell lines from human induced pluripotent stem cells (ipscs) |
JP6388537B2 (ja) | 2011-07-21 | 2018-09-12 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 患者由来の人工多能性幹細胞由来の心筋細胞および使用方法 |
CN104237308B (zh) * | 2013-06-09 | 2016-08-31 | 国家纳米科学中心 | 一种在体外筛选药物的方法 |
US9983198B2 (en) * | 2015-03-19 | 2018-05-29 | Axion Biosystems, Inc. | Systems and methods for assessing data collected from an electrically active cell culture |
EP3423158B1 (en) | 2016-02-24 | 2023-11-15 | The Rockefeller University | Embryonic cell-based therapeutic candidate screening systems, models for huntington's disease and uses thereof |
US11746328B2 (en) | 2017-03-03 | 2023-09-05 | Agilent Technologies, Inc. | Methods and systems for functional maturation of iPSC and ESC derived cardiomyocytes |
USD941488S1 (en) | 2020-02-07 | 2022-01-18 | Agilent Technologies, Inc. | Instrument for analyzing biological cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4441327C1 (de) * | 1994-11-22 | 1995-11-09 | Inst Pflanzengenetik & Kultur | Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung |
DE19727962A1 (de) * | 1997-07-02 | 1999-01-14 | Juergen Hescheler | Fluoreszierende Proteine als zelltypspezifische Reporter |
DE19843234A1 (de) * | 1998-09-09 | 2000-03-23 | Inst Pflanzengenetik & Kultur | Differenzierte Herzzellen mit pathologischen Merkmalen als in vitro-Modell für Herzerkrankungen |
WO2003008535A2 (en) * | 2001-07-20 | 2003-01-30 | Technion Research And Development Foundation Ltd. | Methods of generating human cardiac cells and tissues and uses thereof |
AU2003220562A1 (en) * | 2002-04-01 | 2003-10-20 | Peter K. Law | Cellular transplantation for heart regeneration |
-
2003
- 2003-07-25 CN CNA038179032A patent/CN1671860A/zh active Pending
- 2003-07-25 WO PCT/US2003/023174 patent/WO2004011603A2/en active Application Filing
- 2003-07-25 KR KR1020057001457A patent/KR20050026008A/ko not_active Application Discontinuation
- 2003-07-25 JP JP2004524781A patent/JP2005533518A/ja active Pending
- 2003-07-25 EP EP03771801A patent/EP1551991A4/en not_active Withdrawn
- 2003-07-25 AU AU2003252155A patent/AU2003252155B2/en not_active Expired
- 2003-07-25 MX MXPA05000283A patent/MXPA05000283A/es unknown
- 2003-07-25 CA CA2493588A patent/CA2493588C/en not_active Expired - Lifetime
- 2003-07-25 US US10/627,245 patent/US7611852B2/en not_active Expired - Lifetime
- 2003-07-25 NZ NZ537245A patent/NZ537245A/en not_active IP Right Cessation
- 2003-07-25 BR BR0312764-8A patent/BR0312764A/pt not_active Application Discontinuation
-
2004
- 2004-12-22 IL IL16594304A patent/IL165943A0/xx active IP Right Grant
-
2005
- 2005-01-25 IS IS7663A patent/IS7663A/is unknown
- 2005-02-25 NO NO20051030A patent/NO20051030L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL165943A0 (en) | 2006-01-15 |
MXPA05000283A (es) | 2005-03-31 |
CA2493588C (en) | 2012-09-11 |
IS7663A (is) | 2005-01-25 |
EP1551991A2 (en) | 2005-07-13 |
EP1551991A4 (en) | 2006-09-20 |
AU2003252155B2 (en) | 2009-01-22 |
US7611852B2 (en) | 2009-11-03 |
CA2493588A1 (en) | 2004-02-05 |
KR20050026008A (ko) | 2005-03-14 |
NZ537245A (en) | 2010-04-30 |
JP2005533518A (ja) | 2005-11-10 |
WO2004011603A3 (en) | 2004-07-08 |
BR0312764A (pt) | 2005-07-26 |
AU2003252155A1 (en) | 2004-02-16 |
CN1671860A (zh) | 2005-09-21 |
WO2004011603A2 (en) | 2004-02-05 |
US20040106095A1 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051030L (no) | Funksjonelle kardiomyocytter fra humane embryonale stamceller | |
WO2006044204A3 (en) | Neuronal progenitors from feeder-free human embryonic stem cell culture | |
BR0308919A (pt) | Células-tronco programáveis, desdiferenciadas de origem monocìtica, e sua produção e uso | |
WO2002064748A8 (en) | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
DK1226233T3 (da) | Multipotente voksne stamceller og fremgangsmåder til isolering heraf | |
HUP0500477A2 (hu) | Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával | |
BR0210599A (pt) | Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril | |
EP2471907A3 (en) | Placental stem cell populations | |
WO2007030743A3 (en) | Cochlear implants containing biological cells and uses thereof | |
GB2392674A (en) | Mesenchymal cells and osteoblasts from human embryonic stem cell | |
EP3275901A8 (en) | Human embryonic stem cell methods and podxl expression | |
NO20092741L (no) | DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser | |
WO2005046570A3 (en) | Human stem cell materials and methods | |
WO2004050826A3 (en) | Method of dynamically culturing embryonic stem cells | |
ATE420101T1 (de) | Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern | |
AR039186A1 (es) | Celulas madre indiferenciadas programables de origen monocitaro, su obtencion y uso | |
BR9906926A (pt) | Composições e métodos para tratamento de células tendo dna de minuto duplo | |
WO2004043990A3 (en) | Human stem cell materials and methods | |
WO2003020892A3 (en) | Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY | |
WO2005056763A3 (en) | Process and formulation to improve viability of stored cells and tissue | |
EP1356076A4 (en) | METHODS AND COMPOSITIONS FOR EXTRACTING PROTEINS FROM CELLS | |
MX2007015127A (es) | Oligonucleotidos estimuladores de la proliferacion de celulas madre mesenquimatosas y sus usos. | |
WO2005054447A3 (en) | Müller stem cells | |
DE60141166D1 (de) | Verwendung eines biologischen materials mit dreidimensionalen gerüsten aus hyaluronsäure-derivaten | |
AU8478601A (en) | Methods for culturing human lung mast cells and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |